Frequently Asked Questions
The market is segmented based on , By Test Type (Transthoracic Echocardiogram, Transoesophageal Echocardiogram, Stress Echocardiogram, and Other Echocardiograms), Technology (2D Ultrasound, 3D and 4D Ultrasound, and Doppler Imaging), Device Display (Colour Display and Black and White (B/W) Display), End-User (Hospital and Cardiology Centres, Home and Ambulatory Care Settings, Research Institutes, Medical Device, and Pharmaceutical Companies, and Other End Users) – Industry Trends and Forecast to 2031.
.
The Global Cardiovascular Ultrasound System Market size was valued at USD 1.84 USD Billion in 2023.
The Global Cardiovascular Ultrasound System Market is projected to grow at a CAGR of 5.37% during the forecast period of 2024 to 2031.
The major players operating in the market include GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), FUJIFILM Holdings Corporation (Japan), Siemens Healthineers AG (Germany), Hitachi Medical Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China), Samsung Electronics Co. Ltd. (South Korea), Canon Medical Systems (Japan), Chison Medical Imaging Co. Ltd. (China), Esaote SPA (Italy), Kalamed GmbH Medical Systems (U.S.), Unetixs Vascular, Inc. (U.S.).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
